Parenteral Nutrition Market Share

Based on the regional analysis, the parenteral nutrition market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America industry is poised to account for largest revenue share by 2036, due to increasing cases of chronic diseases such as cancer and diabetes in the region, growing approval of the U.S. FDA approved parenteral nutrition products coupled with increased R&D investment funding by leading companies. The growing prevalence of technologically advanced medical facilities along with the rise in healthcare expenditure and increasing geriatric population are some of the factors expected to hold this region in the leading position during the forecast period

The Asia-Pacific region is expected to witness the fastest growth in terms of revenue during the forecast period on the back of the increasing geriatric population who are more prone to chronic diseases. Additionally, growing awareness of parenteral nutrition, and improving healthcare infrastructure are also anticipated to drive the growth of the market in the region. The developing economies such as China and India are expected to accelerate this region's growth as a result of supportive government policies to develop healthcare infrastructure, and increased corporate investments in the healthcare segment are expected to increase the parenteral nutrition market growth during the forecast period.

The Middle East and Africa and Latin America are also expected to experience moderate growth in the market on account of increasing cases of malnutrition, rising awareness about inflammatory bowel syndrome, and adoption of new parenteral therapies.